Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?
Alpha Vantage · Yahoo Finance · · AI-summarised by FinFlash
This article compares two healthcare ETFs: Fidelity MSCI Health Care Index ETF (FHLC), which offers broad healthcare exposure at a lower cost, and Invesco Biotechnology & Genome ETF (PBE), which focuses on a concentrated, high-growth biotech niche. While FHLC provides diversification and lower fees, PBE targets investors with specific conviction in biotechnology and genomics.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.